GRIFOLS | GRF - Ebitda

Aktienkurs
8.95
Täglich Wechseln
0 0%
Monatlich
-0.11%
Jährlich
5.12%
Q2 Prognose
8.72




Ebitda Veränderung Datum
Alcon AG USD 317M 337M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
Amadeus IT EUR 577.9M 74.8M 2025-12
Amarin USD 12.54M 28.57M 2025-06
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.97B 457M 2025-12
Cie Automotive EUR 345.96M 35.96M 2024-12
Demant DKK 2.76B 165M 2025-12
Ence Energia y Celulosa EUR 12.8M 100K 2025-12
Essilor EUR 3.09B 356M 2024-12
Ferrovial EUR 542M 607M 2025-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Inditex EUR 2.97B 223M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Philips EUR 738M 9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Smith & Nephew USD 796M 139M 2025-12
UCB EUR 1.6B 570M 2025-12
Viscofan EUR 63.38M 8.37M 2026-03